- Tesaro's (TSRO) drug niraparib significantly improved progression-free survival for patients with ovarian cancer in both …

GRAFT VERSUS HOST DISEASE (GVHD) INCYTE (INCY) HAS SEVERAL GOOD NEWS. As a matter of fact, …

Innoviva (INVA) and GlaxoSmithKline plc (GSK) announced positive results from the pivotal Phase 3 FULFIL study …

ARIAD Pharmaceuticals (ARIA) announced the initiation of a New Drug Application (NDA) submission for brigatinib, the …

SPARK Spark (NASDAQ: ONCE) is on its way to get an FDA approval of its first …

Agenus (AGEN) announced that a lead product candidate is selected under its license and research collaboration …

Additional data from pivotal METEOR trial underscore clinically meaningful benefit of Exelixis’ (EXEL) drug Cabometyx™ for …

Biomarin Pharmaceutical’s (BMRN) decision to withdraw its DMD drug Kyndrisa™ (drisapersen) Marketing Authorization Application (MAA) from …

GlaxoSmithKline and Innoviva: The COPD inhaler Relvar® Ellipta® (known as Brio Ellipta in the United States) …

CANCER Everyday something new is discovered that explains cancer behavior, including proliferation, response to treatment, resistance …